Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 3
1(16.7%)
6Total
N/A(5)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03794206Not ApplicableTerminated

Vesair Balloon Confirmatory Trial (VECTOR)

Role: lead

NCT04026347Not ApplicableTerminated

Vesair Clinical Trial

Role: lead

NCT02210273Not ApplicableCompleted

Solace Stress Urinary inContinence Control Efficacy and Safety Study

Role: lead

NCT03082118Not ApplicableCompleted

Vesair Continued Access Trial

Role: lead

NCT01676662Not ApplicableCompleted

Solace European Confirmatory Trial

Role: lead

NCT00492596Phase 3Completed

The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence

Role: lead

All 6 trials loaded